Russia aims to produce ‘millions’ of virus doses by 2021

The country is pushing ahead with several vaccine prototypes and one prepared at the Gamaleya institute in Moscow has reached advanced stages of development. (File/AFP)
Short Url
Updated 03 August 2020

Russia aims to produce ‘millions’ of virus doses by 2021

  • The Gamaleya institute came under fire after researchers and directors injected themselves with the prototype months ago
  • Scientists have told AFP that Russia will struggle to adapt the vaccine to mass production because the country lacks raw materials, adequate facilities and experience

MOSCOW: Russia said Monday it aims to launch mass production of a coronavirus vaccine next month and turn out “several million” doses per month by next year.
The country is pushing ahead with several vaccine prototypes and one prepared at the Gamaleya institute in Moscow has reached advanced stages of development.
“We are very much counting on starting mass production in September,” industry minister Denis Manturov said in an interview published by TASS news agency.
“We will be able to ensure production volumes of several hundred thousand a month, with an eventual increase to several million by the start of next year,” he said, adding that one developer is preparing production technology at three locations in central Russia.
Health Minister Mikhail Murashko on Saturday said the Gamaleya vaccine had “completed clinical trials” and that documents were being prepared to register it with the state.
Another vaccine, developed by Siberia-based Vektor lab, is currently undergoing clinical trials and two more will begin human testing within the next two months, Murashko said.
Gamaleya’s vaccine is a so-called viral vector vaccine, meaning it employs another virus to carry the DNA encoding of the needed immune response into cells.
Gamaleya’s vaccine employs the adenovirus, a similar technology to the coronavirus vaccine prototype developed by China’s CanSino, currently in the advanced stage of clinical trials.
The Gamaleya institute came under fire after researchers and directors injected themselves with the prototype months ago, with specialists criticizing the move as an unorthodox and rushed way of starting human trials.
Scientists have told AFP that Russia will struggle to adapt the vaccine to mass production because the country lacks raw materials, adequate facilities and experience, particularly with advanced technology like viral vector.
Some Russian officials have boasted that the country will be the first to come up with the vaccine, even comparing it to the space race to produce the first satellite in the Soviet era.
Moscow has dismissed allegations from the UK, the United States and Canada that a hacking group linked to Russian intelligence services tried to steal information about a coronavirus vaccine from labs in the West.
Russia’s coronavirus caseload is currently fourth in the world after the United States, Brazil and India.


UK science advisers warn public on COVID-19 rates

Updated 21 September 2020

UK science advisers warn public on COVID-19 rates

  • Prime Minister Boris Johnson huddled with ministers over the weekend to discuss how the government will respond to the recent rise in cases
  • The UK reported a seven-day average of 21 deaths a day last week

LONDON: Britain’s top medical adviser says the country has, in a “very bad sense,” turned a corner on COVID-19 infection rates, with figures suggesting there will be an exponential growth in the disease unless action is taken.
Chief Medical Officer Chris Whitty told the public on Monday that rates are going in the “wrong direction” amid expectations the government is preparing to announce new measures to control the pandemic.
“We have in a very bad sense, literally turned a corner,” after weeks of increasing infection rates.
Whitty said that if nothing is done, new infections will rise to 49,000 a day by mid-October. Hospitalizations are also doubling in seven to eight days — leading to more deaths.
There was also no indication that the virus had lessened in severity, he said. “We see no evidence that this is true.”
Prime Minister Boris Johnson huddled with ministers over the weekend to discuss how the government will respond to the recent rise in cases, which has pushed infection rates to levels last seen in May. Later this week the government is expected to announce a slate of short-term restrictions that will act as a “circuit breaker” to slow the spread of the disease.
The government is hoping to keep that number from climbing back to the peak levels of early April, when more than 5,000 cases a day were being reported.
While death rates have remained relatively low so far, public health officials warn that deaths are likely to rise in coming weeks.
The UK reported a seven-day average of 21 deaths a day last week, compared with a peak of 942 on April 10.
The government last week imposed tighter restrictions on communities in northeastern England, where the infection rate first began to rise. Bars and restaurants in those areas must now close between 10 p.m. and 5 a.m. and people are prohibited from socializing with individuals from other households.
The rise in infection rates comes as lawmakers across the political spectrum criticize the government’s testing program. While government ministers tout the record numbers of tests being performed, there are widespread reports of people having to travel hundreds of miles for tests and tests being voided because it is taking labs too long to process them.
An effective testing program is seen as essential to controlling the pandemic because it allows the government to track infections and inform people when they should self-isolate.